How much can Jialuohua Shanghai reimburse?

70%-80%。 Gallowax (Autotuzumab Injection) is a new humanized anti-CD20 monoclonal antibody. It was approved for marketing by China Pharmaceutical Products Supervision and Administration (NMPA) in June 20021year, and was listed in the national medical insurance catalogue in July 201year. The reimbursement rate of Shanghai medical insurance is 70%-80%. After being included in medical insurance, the domestic standard of rituximab is 100mg/ 10ml/ bottle, and the cost is about 2294.44 yuan.